Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.

Employees

Sector

Drug Retailers

More about the company

Quotes

Date	Price	Change	Volume
23/26/23	$0.8310	-0.48%	11,766
22/26/22	$0.8350	+1.53%	20,980
21/26/21	$0.8224	-1.01%	2,211
20/26/20	$0.8308	+0.07%	9,938
19/26/19	$0.8302	-0.76%	26,732

Delayed Quote Nasdaq

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Real-time Estimate Cboe BZX 11:05:33 23/10/2026 pm IST			5-day change	1st Jan Change
0.8180 ^USD	-2.04%		-0.66%	-99.81%

31/07	Ridgetech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026	CI
21/07	Top Premarket Gainers	MT

Market Cap	30.31L 27.06L 25L 22.66L 42.39L 29Cr 43.09L 3.01Cr 1.19Cr 15Cr 1.14Cr 1.11Cr 48Cr	P/E 2025	0.57x	P/E 2026	-0.28x
Enterprise Value	-1.49Cr -1.33Cr -1.23Cr -1.11Cr -2.08Cr -140.99Cr -2.11Cr -15Cr -5.84Cr -74Cr -5.57Cr -5.46Cr -232.89Cr	EV / Sales 2025	0.03x	EV / Sales 2026	-0.13x
Free-Float	99.59%	Yield 2025 *	-	Yield 2026	-

Markets		Quality
Nasdaq	RDGT	Delayed
CBOE	RDGT	Real-time

31/07	Ridgetech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026	CI
21/07	Top Premarket Gainers	MT
23/06	Top Premarket Gainers	MT
06/03	Ridgetech, Inc. Reports Earnings Results for the Half Year Ended September 30, 2025	CI
04/03	Ridgetech unveils 2026 dual-engine growth strategy to drive innovation and value creation	RE
30/12	Ridgetech Inc on December 29, 2025 co entered into sales agreement with AC SUNSHINE SECURITIES -SEC filing	RE
30/25/30	Ridgetech, Inc. announced that it expects to receive $2.808 million in funding	CI
28/25/28	Ridgetech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
28/25/28	Ridgetech reports fiscal year 2025 financial results	RE
03/25/03	Ridgetech, Inc. Approves the Appointment of Lingtao Kong as Director	CI
28/25/28	China Jo-Jo Drugstores, Inc. acquired Ridgeline International Limited from Lingtao Kong for CNY 25.65 million.	CI
03/25/03	Li Qi and Lei Liu of China Jo-Jo Drugstore agreed to acquire drug retail business of China Jo-Jo Drugstore from China Jo-Jo Drugstores, Inc. for RM 29.378976 million.	CI
03/25/03	China Jo-Jo Drugstores, Inc. agreed to acquire Allright Internet Technology Co. Ltd.	CI

Ridgetech, Inc. Share Price

Stocks

RDGT

KYG2124G2037

Drug Retailers

Valuation: Ridgetech, Inc.

Chart: Ridgetech, Inc.

Latest news: Ridgetech, Inc.

Press Releases: Ridgetech, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Ridgetech, Inc.

Latest insider transactions

Other Drug Retailers

Financials

Company Profile

Quotes

24/07	Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association	PR
03/04	Ridgetech, Inc. Announces 1-for-150 Reverse Share Split	PR
04/03	Ridgetech Unveils 2026 Dual-Engine Growth Strategy to Drive Innovation and Value Creation	PR
28/25/28	Ridgetech, Inc. Reports Fiscal Year 2025 Financial Results	PR
17/24/17	China Jo Jo Drugstores : Report Of Foreign Private Issuer - Form 6-K	PU

1 day	-2.04%
1 week	-0.66%
Current month	+0.72%
1 month	-10.17%
3 months	-40.22%
6 months	-53.31%
Current year	-99.81%

1 week	0.8	0.86
1 month	0.76	1.3
Current year	0.67	702
1 year	0.67	760.5
3 years	0.67	760.5
5 years	0.67	35,369.84
10 years	0.67	1,24,559.45

Director	Title	Age	Since
Caroline Wang BRD	Director/Board Member	38	03/10/2009
Geng Hua Gu BRD	Director/Board Member	75	28/03/2014
Jiang Liang He BRD	Director/Board Member	63	04/09/2018

Date	Insider	Type	Main position	Quantity	% Market Cap.	Importance
01/07/26	HRT Financial LP	Buy	Company	10,197	0.2809%
30/06/26	HRT Financial LP	Other	Company	90,302	2.4880%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
RIDGETECH, INC.	-2.04%	-0.66%	-99.69%	-99.88%	30.31L
JD HEALTH INTERNATIONAL INC.	-1.00%	-0.37%	-39.21%	+6.52%	1.55TCr
RAIA DROGASIL S.A.	+10.14%	-1.61%	+6.42%	-22.13%	704.52Cr
MATSUKIYOCOCOKARA & CO.	-0.06%	+3.55%	-9.49%	+2.50%	656.83Cr
TSURUHA HOLDINGS INC.	+2.02%	+2.37%	-16.33%	+5.72%	629.8Cr
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+0.70%	-3.21%	-52.25%	-36.33%	586.86Cr
YIFENG PHARMACY CHAIN CO., LTD.	-1.13%	-2.08%	+1.00%	-4.87%	465.82Cr
CLICKS GROUP LIMITED	-3.56%	-4.21%	-37.89%	-2.02%	326.66Cr
COSMOS PHARMACEUTICAL CORPORATION	+0.41%	-1.41%	-14.04%	-10.97%	318.81Cr
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-0.77%	-3.09%	-4.02%	-21.49%	312.18Cr
Average	+0.48%	-0.99%	-26.55%	-18.30%	554.76Cr
Weighted average by Cap.	+0.99%	-0.53%	-21.80%	-6.27%

	2025	2026
Net sales	12Cr 11Cr 9.9Cr 8.97Cr 17Cr 1.14TCr 17Cr 119.1Cr 47Cr 596.7Cr 45Cr 44Cr 1.88TCr	13Cr 12Cr 11Cr 9.88Cr 18Cr 1.25TCr 19Cr 131.2Cr 52Cr 657.34Cr 50Cr 49Cr 2.07TCr
Net income	1.02Cr 91.04L 84.1L 76.21L 1.43Cr 97Cr 1.45Cr 10Cr 4.01Cr 51Cr 3.83Cr 3.74Cr 159.86Cr	-12.5L -11.17L -10.32L -9L -17.49L -12Cr -17.78L -1.24Cr -49.15L -6.22Cr -46.93L -45.93L -20Cr
Net Debt	-23.91L -21.35L -19.73L -17.88L -33.44L -23Cr -34L -2.37Cr -93.98L -12Cr -89.73L -87.83L -37Cr	-1.79Cr -1.6Cr -1.48Cr -1.34Cr -2.5Cr -169.76Cr -2.54Cr -18Cr -7.03Cr -89Cr -6.71Cr -6.57Cr -280.41Cr